Diasorin SpA (CHIX:DIAM) 5-Year EBITDA Growth Rate : 4.30% (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA 5-Year EBITDA Growth Rate?

Diasorin SpA's EBITDA per Share for the three months ended in Mar. 2025 was €1.36.

During the past 12 months, Diasorin SpA's average EBITDA Per Share Growth Rate was 76.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Diasorin SpA was 40.50% per year. The lowest was -7.40% per year. And the median was 13.40% per year.

Competitive Comparison of Diasorin SpA's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Diasorin SpA's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Diasorin SpA 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Diasorin SpA (CHIX:DIAm) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Diasorin SpA 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

DSRLF:USA DIA:Italy 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines